Legend:
CC = Baltimore Convention Center, H = Hilton Baltimore
* = applied session ! = JSM meeting theme
Activity Details
|
|
|
|
223 * !
|
Mon, 7/31/2017,
2:00 PM -
3:50 PM
|
CC-315
|
|
Clinical Trials: Recent Statistical Advances for Enabling Personalized Medicine — Topic Contributed Papers
|
|
Biopharmaceutical Section , Section on Statistics in Genomics and Genetics , Section on Medical Devices and Diagnostics
|
|
Organizer(s): Devan Mehrotra, Merck & Co. Inc.
|
|
Chair(s): Donna L Kowalski, Astellas Pharma, US
|
|
2:05 PM
|
Methods of Biomarker and Subgroup Identification for Personalized Medicine
—
Ilya Lipkovich, QuintilesIMS ; Bohdana Ratitch , QuintilesIMS ; Alex Dmitrienko, Mediana Inc
|
|
2:25 PM
|
Measuring Differential Treatment Benefit Across Marker Specific Subgroups: The Choice of Outcome Scale
—
Alexia Iasonos, Memorial Sloan Kettering Sloan Cancer Center ; Jaya Satagopan, Memorial Sloan Kettering Cancer Center
|
|
2:45 PM
|
A Powerful Learn-And-Confirm Pharmacogenomics Methodology for Randomized Clinical Trials
—
Devan Mehrotra, Merck & Co. Inc. ; Qian Guan, North Carolina State University ; Zifang Guo, Merck & Co., Inc.
|
|
3:05 PM
|
Efficient Approaches to Identifying Markers That Predict Treatment Effects in Randomized Clinical Trials
—
James Dai, Fred Hutchinson Cancer Research Center ; Michael LeBlanc, Fred Hutchinson Cancer Research Center
|
|
3:25 PM
|
Clinical Trial Designs of Predictive Markers
—
Meijuan Li, CDRH/FDA
|
|
3:45 PM
|
Floor Discussion
|
|
